Literature DB >> 11233991

2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity.

N Hauptmann1, J C Shih.   

Abstract

Cigarette smokers exhibit a lower monoamine oxidase (MAO; EC 1.4.3.4) activity than nonsmokers. MAO is located in the outer membrane of mitochondria and exists as two isoenzymes, MAO A and B. MAO A prefers 5-hydroxytryptamine (serotonin), and MAO B prefers phenylethylamine (PEA) as substrate. Dopamine is a substrate for both forms. 2-Naphthylamine is a carcinogen found in high concentrations in cigarette smoke. The results of this study show that 2-naphthylamine has the ability to inhibit mouse brain MAO A and B in vitro by mixed type inhibition (competitive and non-competitive). The Ki for MAO A was determined to be 52.0 microM and for MAO B 40.2 microM. The inhibitory effect of 2-naphthylamine on both MAO A and B catalytic activity, supports the hypothesis that smoking decreases MAO activity in vivo, instead that smokers with lower MAO activity are more prone to become a smoker.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11233991     DOI: 10.1016/s0024-3205(00)01022-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

Review 1.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

2.  Cigarette smoke inhibits brain mitochondrial adaptations of exercised mice.

Authors:  Ana Elisa Speck; Daiane Fraga; Priscila Soares; Débora L Scheffer; Luciano A Silva; Aderbal S Aguiar; Emílio L Estreck; Ricardo A Pinho
Journal:  Neurochem Res       Date:  2011-03-22       Impact factor: 3.996

3.  A systematic review and meta-analysis examining the interrelationships between chemical and non-chemical stressors and inherent characteristics in children with ADHD.

Authors:  Frances M Nilsen; Nicolle S Tulve
Journal:  Environ Res       Date:  2019-11-01       Impact factor: 6.498

4.  Evidence of sex differences in the relationship between current tobacco use and past-year serious psychological distress: 2005-2008 National Survey on Drug Use and Health.

Authors:  Nicholas Peiper; Brad Rodu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-12-28       Impact factor: 4.328

5.  A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch.

Authors:  Ivan Berlin; Ian M Hunneyball; Doris Greiling; Stephen P Jones; Hermann Fuder; Hans-Detlev Stahl
Journal:  Psychopharmacology (Berl)       Date:  2012-03-27       Impact factor: 4.530

Review 6.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

Review 7.  Perspectives on MAO-B in aging and neurological disease: where do we go from here?

Authors:  M Jyothi Kumar; Julie K Andersen
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

Review 8.  Monoamine oxidase inhibition for tobacco pharmacotherapy.

Authors:  T P George; A H Weinberger
Journal:  Clin Pharmacol Ther       Date:  2007-12-19       Impact factor: 6.875

9.  Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats.

Authors:  Matthew R Costello; Daisy D Reynaga; Celina Y Mojica; Nurulain T Zaveri; James D Belluzzi; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2014-02-11       Impact factor: 7.853

10.  Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase.

Authors:  Kay Castagnoli; Stefanus J Steyn; Geraldine Magnin; Cornelis J Van Der Schyf; Izel Fourie; Ashraf Khalil; Neal Castagnoli
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.